Edward Wolin, MD

Articles by Edward Wolin, MD

Dr. Wolin on the Treatment Landscape of NETs

ByEdward Wolin, MD

October 29th 2020

Edward Wolin, MD, discusses the current treatment landscape of neuroendocrine tumors.

Dr. Wolin on the Safety of Lutathera in Advanced NETs

ByEdward Wolin, MD

October 2nd 2020

Edward Wolin, MD, discusses the safety profile of 177Lu-dotatate in patients with advanced neuroendocrine tumors.

Latest Updated Articles

Dr. Wolin on the Safety of Lutathera in Advanced NETs
October 2nd 2020
Dr. Wolin on the Treatment Landscape of NETs
October 29th 2020

Trending on OncLive

Sacituzumab Govitecan Triplet Elicits Durable Responses in Treatment-Naive Metastatic Urothelial Cancer

Perioperative Enfortumab Vedotin Plus Pembrolizumab Improves ctDNA Clearance in Cisplatin-Eligible MIBC

Pembrolizumab Plus Chemo Misses EFS End Point in Cisplatin-Eligible MIBC

Atirmociclib Plus Fulvestrant Improves PFS in HR+/HER2– Advanced Breast Cancer

Surufatinib Plus Serplulimab and Chemo Shows Activity in First-Line Extrapulmonary NEC